Breaking News Instant updates and real-time market news.

SUPN

Supernus

$53.50

0.55 (1.04%)

16:33
08/07/18
08/07
16:33
08/07/18
16:33

Supernus narrows FY18 product sales view to $385M-$400M from $375M-$400M

For full year 2018, the company is updating its prior view of net product sales to $385M-$400M, compared to the previously expected range of $375M-$400M. FY18 revenue consensus $403.9M. Now sees operating earnings in the range of $130M-$140M, compared to the previously expected range of $125M-$135M. The company continues to expect approximately $7M of licensing and non-cash royalty revenue.

  • 08

    Aug

SUPN Supernus
$53.50

0.55 (1.04%)

12/04/17
JANY
12/04/17
UPGRADE
Target $47
JANY
Buy
Supernus upgraded to Buy from Neutral at Janney Capital
Janney Capital analyst Ken Trbovich upgraded Supernus to Buy from Neutral, calling it the best positioned among the companies he covers to be an immediate beneficiary of lower U.S. corporate tax rates, which now appear highly likely for 2018 following the passage of tax bills in both the Senate and House. Reducing the Federal corporate tax rate from 35% to 22% would boost his 2018 EPS estimate for Supernus to $1.72 from $1.48 per share, noted Trbovich, who reiterated a $47 fair value estimate on the stock.
02/01/18
BREN
02/01/18
INITIATION
Target $66
BREN
Buy
Supernus initiated with a Buy at Berenberg
Berenberg analyst Patrick Trucchio initiated Supernus with a Buy and $66 price target.
04/18/18
JEFF
04/18/18
NO CHANGE
Target $54
JEFF
Buy
Supernus on track to exceed guidance, says Jefferies
After hosting investor meetings with management, Jefferies analyst David Steinberg believes Supernus Pharmaceuticals looks on track to exceed guidance for the year. Supernus will likely buy an asset this year, with a focus likely on a pipeline candidates versus drug on the market, Steinberg tells investors in a research note. He notes the company has a $640M war chest. The analyst keeps a Buy rating on the shares with a $54 price target.
07/02/18
PIPR
07/02/18
NO CHANGE
Target $47
PIPR
Neutral
Piper sees 'more tepid sales growth trajectory' for Supernus
Piper Jaffray analyst David Amsellem says that while his survey of 25 neurologists did not necessarily suggest that Supernus Pharmaceuticals' (SUPN) migraine prophylaxis treatment Trokendi XR will see pressure due to the availability of Amgen's (AMGN) Aimovig, there were data points that suggest Trokendi's volume growth "could slow meaningfully. 64% of respondents have patients with either moderate or significant difficulty with insurance coverage when trying to get a Trokendi XR prescription filled, Amsellem tells investors in a research note. He sees a "more tepid sales growth trajectory" for Trokendi XR going forward and reiterates a Neutral rating on Supernus with a $47 price target.

TODAY'S FREE FLY STORIES

AMRN

Amarin

$19.82

0.4 (2.06%)

11:08
06/20/19
06/20
11:08
06/20/19
11:08
On The Fly
Jefferies sees Amarin stock poised for even more gains »

Seeing the stock's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

STLD

Steel Dynamics

$29.25

-0.45 (-1.52%)

11:05
06/20/19
06/20
11:05
06/20/19
11:05
Options
Steel Dynamics call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSON

Misonix

$23.52

(0.00%)

11:04
06/20/19
06/20
11:04
06/20/19
11:04
Hot Stocks
Breaking Hot Stocks news story on Misonix »

Misonix up 39c to $24.17…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MLNT

Melinta Therapeutics

$5.28

-1.02 (-16.19%)

11:04
06/20/19
06/20
11:04
06/20/19
11:04
Recommendations
Melinta Therapeutics analyst commentary  »

Gabelli fears Melinta…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSON

Misonix

$23.52

(0.00%)

11:03
06/20/19
06/20
11:03
06/20/19
11:03
Hot Stocks
SEC tells Misonix investigation concluded, no enforcement action recommended »

Misonix announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PSNL

Personalis

$0.00

(0.00%)

10:59
06/20/19
06/20
10:59
06/20/19
10:59
Syndicate
Personalis indicated to open at $28, IPO priced at $17 »

Personalis (PSNL) priced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

AGCO

Agco

$75.20

0.33 (0.44%)

10:57
06/20/19
06/20
10:57
06/20/19
10:57
Conference/Events
Agco management to meet with Oppenheimer »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

  • 24

    Jun

  • 25

    Jun

  • 26

    Jun

WORK

Slack Technologies

$0.00

(0.00%)

10:54
06/20/19
06/20
10:54
06/20/19
10:54
Syndicate
Breaking Syndicate news story on Slack Technologies »

Slack Technologies direct…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GDX

VanEck Vectors Gold Miners ETF

$24.79

0.82 (3.42%)

10:50
06/20/19
06/20
10:50
06/20/19
10:50
Options
Recent call buyer in Gold Miners ETF hit the mother lode on Fed stance »

Recent call buyer in Gold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMC

AMC Entertainment

$11.13

-0.39 (-3.39%)

10:45
06/20/19
06/20
10:45
06/20/19
10:45
Options
AMC Entertainment call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

10:45
06/20/19
06/20
10:45
06/20/19
10:45
General news
Breaking General news story  »

3-Month Bill Announcement…

10:45
06/20/19
06/20
10:45
06/20/19
10:45
General news
Breaking General news story  »

6-Month Bill Announcement…

TSN

Tyson Foods

$77.87

0.1 (0.13%)

10:45
06/20/19
06/20
10:45
06/20/19
10:45
Earnings
Tyson Foods sees adjusted EPS growth in 'high single digits' »

In analyst day slides,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

AAPL

Apple

$198.90

1.03 (0.52%)

10:44
06/20/19
06/20
10:44
06/20/19
10:44
Hot Stocks
Apple, in letter to Lighthizer, urges U.S. not to impose additional tariffs »

Apple said in a letter to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JBLU

JetBlue

$19.16

0.11 (0.58%)

, EADSY

Airbus

$0.00

(0.00%)

10:43
06/20/19
06/20
10:43
06/20/19
10:43
Periodicals
JetBlue to order 13 A321XLR aircraft from Airbus, Reuters says »

JetBlue (JBLU) will order…

JBLU

JetBlue

$19.16

0.11 (0.58%)

EADSY

Airbus

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BCEL

Atreca

$0.00

(0.00%)

10:40
06/20/19
06/20
10:40
06/20/19
10:40
Syndicate
Breaking Syndicate news story on Atreca »

Atreca opens at $19.90,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

DPUKY

Domino's Pizza Group

$0.00

(0.00%)

10:38
06/20/19
06/20
10:38
06/20/19
10:38
Periodicals
Domino's Pizza Group in talks to replace CEO, Sky News reports »

Domino's Pizza Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

W

Wayfair

$160.99

-1.56 (-0.96%)

10:35
06/20/19
06/20
10:35
06/20/19
10:35
Options
Wayfair put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANIP

ANI Pharmaceuticals

$76.25

1.86 (2.50%)

10:33
06/20/19
06/20
10:33
06/20/19
10:33
Hot Stocks
ANI Pharmaceuticals announces FDA approval for Vancomycin supplement »

ANI Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACRS

Aclaris Therapeutics

$5.25

0.14 (2.74%)

10:31
06/20/19
06/20
10:31
06/20/19
10:31
Hot Stocks
FDA says Aclaris ad makes false or misleading claims about Eskata »

The FDA sent a letter to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:30
06/20/19
06/20
10:30
06/20/19
10:30
General news
EIA natural gas storage change for week ending June 14 »

Gas inventories 115 Bcf…

10:30
06/20/19
06/20
10:30
06/20/19
10:30
General news
Treasury Action: Treasuries remain richer on the day »

Treasury Action:…

GO

Grocery Outlet

$0.00

(0.00%)

10:28
06/20/19
06/20
10:28
06/20/19
10:28
Syndicate
Grocery Outlet indicated to open at $30, IPO priced at $22 »

Grocery Outlet (GO)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

10:27
06/20/19
06/20
10:27
06/20/19
10:27
General news
Trump tweets 'Iran made a very big mistake' »

President Trump tweeted,…

BCEL

Atreca

$0.00

(0.00%)

10:25
06/20/19
06/20
10:25
06/20/19
10:25
Syndicate
Atreca indicated to open at $20.30, IPO priced at $17.00 »

Atreca (BCEL) priced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.